Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-Small Cell Lung Cancer

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2020.00125
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Nivolumab in Metastatic Non–Small Cell Lung Cancer

Journal of the Advanced Practitioner in Oncology
2016English

Neutrophil-To-Lymphocyte Ratio as an Early Marker of Outcomes in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Nivolumab

International Journal of Clinical Oncology
MedicineSurgeryOncologyHematology
2018English

Real-World Data on Nivolumab Treatment of Non-Small Cell Lung Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2016English

Quantitative P16 and ESR1 Methylation in the Peripheral Blood of Patients With Non-Small Cell Lung Cancer

Oncology Reports
MedicineCancer ResearchOncology
1994English

Neutrophil to Lymphocyte Ratio (NLR) in Peripheral Blood: A Novel and Simple Prognostic Predictor of Non-Small Cell Lung Cancer (NSCLC)

2017English

Correlation Between KRAS Mutation Status and Response to Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer☆

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2016English

Gene Expression Profiles in Peripheral Blood Mononuclear Cells Can Distinguish Patients With Non-Small Cell Lung Cancer From Patients With Nonmalignant Lung Disease

Cancer Research
Cancer ResearchOncology
2009English

Cis-Diamminedichloroplatinum (CDDP)-fosfomycin (FOM) Combination in Lung Cancer Patients With Respect to the Peripheral T Lymphocyte Subsets.

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1986English

Response to Treatment and Survival of Patients With Non-Small Cell Lung Cancer Undergoing Somatic EGFR Mutation Testing

Oncologist
Cancer ResearchMedicineOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy